Royalty Pharma (RPRX) EBIT Margin (QoQ) (2019 - 2026)
Royalty Pharma (RPRX) EBIT Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Royalty Pharma | 25.78 Bn | 28.22 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,685.00 |
| Dec 31, 2025 | -767.00 |
| Sep 30, 2025 | 3,385.00 |
| Jun 30, 2025 | -5,775.00 |
| Mar 31, 2025 | 3,311.00 |
| Dec 31, 2024 | -6,928.00 |
| Sep 30, 2024 | 7,999.00 |
| Jun 30, 2024 | 6,317.00 |
| Mar 31, 2024 | -11,581.00 |
| Dec 31, 2023 | 7,459.00 |
| Sep 30, 2023 | -1,800.00 |
| Jun 30, 2023 | -2,379.00 |
| Mar 31, 2023 | 15,534.00 |
| Dec 31, 2022 | -11,883.00 |
| Sep 30, 2022 | -3,697.00 |
| Jun 30, 2022 | 3,140.00 |
| Mar 31, 2022 | 1,244.00 |
| Dec 31, 2021 | -2,509.00 |
| Sep 30, 2021 | -8,250.00 |
| Jun 30, 2021 | 9,422.00 |